OBD’s 94% accurate EpiSwitch® Prostate Screening (PSE) blood test is now available to men being screened for prostate cancer.

PSE boosts PSA accuracy from 55% to 94% for confirming the presence or absence of prostate cancer. The highly accurate blood test is simple to order by a physician and is available to men in the US and UK under the immediate access program.

Read more here

Order the PSE Test here

Continue

Featured Stories

Filter by:

Q&A: Analyzing Blood, Not the Tumor: A Novel Test for Personalized Cancer Immunotherapy

GenomeWeb |
View Article

New prostate cancer blood test combining PSA with epigenetic test could reduce biopsies

Cancerworld |
View Article

Scientists create ‘impressive’ new blood test for prostate cancer that is 94% accurate

The Independent |
View Article

New prostate cancer test could spare men from needless biopsies

The Telegraph |
View Article

New prostate cancer test is 94% accurate and could stop unnecessary biopsies, researchers say

ITV News |
View Article

Oxford BioDynamics’ Prostate Screening EpiSwitch® Blood Test Significantly Enhances Overall Detection Accuracy For At Risk Men

BioSpace |
View Article